Skip to main content

New Hope for Traumatic Brain Injury and Stroke Survivors

  • Synopsis: Published: 2012-11-01 - Positive effects from the drug etanercept represents therapeutic possibilities for stroke and TBI patients. For further information pertaining to this article contact: Springer Select.
Traumatic Brain Injury
Traumatic Brain Injury - (TBI), also known as intracranial injury, occurs when an external force traumatically injures the brain. TBI can be classified based on severity, mechanism (closed or penetrating head injury), or other features (e.g. occurring in a specific location or over a widespread area). Head injury usually refers to TBI, but is a broader category because it can involve damage to structures other than the brain, such as the scalp and skull.
  • Stroke - The rapidly developing loss of brain functions due to a disturbance in the blood vessels supplying blood to the brain. This can be due to ischemia (lack of blood supply) caused by thrombosis or embolism or due to a hemorrhage. As a result, the affected area of the brain is unable to function, leading to inability to move one or more limbs on one side of the body, inability to understand or formulate speech or inability to see one side of the visual field.
  • Main Document

    A new ground-breaking study about to be published in the Adis journal CNS Drugs provides clinical evidence that, for the first time, chronic neurological dysfunction from stroke or traumatic brain injury can rapidly improve following a single dose of a drug that targets brain inflammation, even years after the stroke or traumatic event.

    The observational study(1) of 629 patients, conducted over the course of nearly two years, documents a diverse range of positive effects, including statistically significant rapid clinical improvement in motor impairment, spasticity, cognition, etc. in the stroke group, with a similar pattern of improvement seen in the traumatic brain injury (TBI) group.

    The study involved 617 patients treated an average of 42 months after stroke and 12 patients treated an average of 115 months after TBI, long after further spontaneous meaningful recovery would be expected.

    The study was conducted at the Institute of Neurological Recovery (INR) in the USA.

    The drug utilized was etanercept, a therapeutic that selectively binds and neutralizes an inflammatory immune molecule that may remain elevated for years following stroke. Etanercept was administered utilizing a novel delivery method, invented by Edward Tobinick M.D., lead author of the study.

    "These results represent a sea change in the therapeutic possibilities for stroke and TBI patients," said Steven Ralph PhD, Associate Professor at Griffith University School of Medical Science in Australia. "Rarely do we see such a radical breakthrough in medical treatment as this for stroke. A previous example was the advance with thrombolytic therapy using drugs such as tissue plasminogen activator (t-PA) for the treatment of acute stroke with their significant impact when applied at the early stages. However, no similar treatment has existed for chronic stroke until now." Professor Ralph recently led a team of physicians to the INR for training in the new etanercept delivery method, prior to their initiation of randomized trials in Australia. "Our team observed, first hand, rapid clinical improvement in stroke patients following this brief office treatment," said Professor Ralph.

    In an accompanying editorial(2), Professor Ian Clark, a world expert on tumor necrosis factor (TNF) and brain dysfunction, discusses the science underlying the novel treatment method and clinical results. The high prevalence of chronic post-stroke and post-TBI neurological disability, with millions of individuals affected worldwide, highlights the study's significance.

    References:

    1. Tobinick E, Kim N, Reyzin G, et al. Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury - An Observational Study Involving 629 Consecutive Patients Treated with Perispinal Etanercept. CNS Drugs. 2012;16(12). DOI 10.1007/s40263-012-0013-2

    2. Clark, I. New Hope for Survivors of Stroke and Traumatic Brain Injury. CNS Drugs. 2012;16(12). DOI 10.1007/s40263-012-0014-1

    Related Information:

    1. The Realities of a Brain Injury - Informative article examines TBI including signs symptoms and importance of seeking medical aid as soon as possible.
    2. Preventing Secondary Damage After Traumatic Brain Injury - Targeted Oxidation-blocker - Researchers developed agent XJB-5-131 which can cross the blood-brain barrier and prevent oxidation of cardiolipin.
    3. Etanercept Helps Restore Normal Growth in Children with Juvenile Arthritis - Etanercept helps restore normal growth in children with juvenile arthritis.




    Information from our Traumatic Brain Injury: TBI & Concussion Information section - (Full List).


         What will I receive?

    Loan Information for low income singles, families, seniors and disabled. Includes home, vehicle and personal loans.


    Famous People with Disabilities - Well known people with disabilities and conditions who contributed to society.


    List of awareness ribbon colors and their meaning. Also see our calendar of awareness dates.


    Blood Pressure Chart - What should your blood pressure be. Also see information on blood group types and compatibility.


    1. #Bonespiration: Hashtag Used to Promote Skeletal Images on Social Media
    2. Special Unit: Action Comedy Film Led By Cast of Actors with Disabilities
    3. Can Adults Develop ADHD?
    4. OHEL Diverse Programs for Children and Adults with Disabilities




    Citation